Survivin is a member of the inhibitor of apoptosis proteins (IAP) family that inhibits capase 3, 7, and 9, and its expression is higher in OSCC patients than in epithelial dysplasia patients. This evidence concerns the gene BIRC5 and intraepithelial neoplasia.